![](/img/cover-not-exists.png)
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
Dennis A Revicki, Alan Menter, Steven Feldman, Miriam Kimel, Neesha Harnam, Mary K WillianVolume:
6
Language:
english
DOI:
10.1186/1477-7525-6-75
Date:
December, 2008
File:
PDF, 560 KB
english, 2008